Trial · NCT07131280
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Transplant-free survival of GCSF + darbepoetin in patients with early decompensated cirrhosis in both groups. | 3 year | |
| Secondary | Transplant-free survival | 6-month, one year, 2 year and 3 year | |
| Secondary | Proportion of patient developed new-onset of Liver Related Event (such as ascites, hepatic encephalopathy , acute kidney injury, bleed and sepsis) or show mortality in both the groups | 6-month, one year, 2 year and 3 year | |
| Secondary | Cumulative incidence of sepsis, acute kidney injury or secondary organ dysfunction in both groups | 6-month, one year, 2 year and 3 year | |
| Secondary | Cumulative incidence of second decompensation | 6-month, one year, 2 year and 3 year | |
| Secondary | Improvement in liver disease severity indices, including the Child-Turcotte-Pugh (CTP) score (ΔCTP). | 6-month, one year, 2 year and 3 year | |
| Secondary | Improvement in liver disease severity indice like Model for End-Stage Liver Disease (MELD) score (ΔMELD). | 6-month, one year, 2 year and 3 year | |
| Secondary | Proportion of patients completing treatment without major adverse effects | 6-month, one year, 2 year and 3 year | Adverse effects will be graded in accordance to CTCAE |
| Secondary | Impact on liver injury (assessed by AST and ALT levels in blood). | 6-month, one year, 2 year and 3 year | |
| Secondary | Impact on fibrosis (evaluated using Masson's Trichome stain and the Enhanced Liver Fibrosis [ELF] score). | 6-month, one year, 2 year and 3 year | |
| Secondary | Impact on regeneration (measured by plasma Alpha-Fetoprotein levels). | 6-month, one year, 2 year and 3 year | |
| Secondary | Impact on bone marrow stem cell reserve (CD34⁺ cell count in peripheral blood) | One year, 2 year and 3 year |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07131280/registered